Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Emerging Trends, Segment Analysis and Industry Forecast 2022 - 2030 | Acandis GmbH, Medtronic, Stryker, Terumo Corporation

Intracranial Atherosclerotic Disease (ICAD) is a condition in which the walls of the arteries supplying blood to the brain become thickened and narrowed due to the buildup of plaque. This condition is a leading cause of stroke, especially in certain populations such as Asians, Hispanics, and Africans. The ICAD pathology market is a rapidly growing market due to the increasing prevalence of the disease and the need for effective treatment options.

In terms of revenue, global intracranial atherosclerotic disease (ICAD) pathology market is growing at a CAGR of 5.62% over the forecast period (2022 - 2030).

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1118

The rising prevalence of ICAD is a key driver of the market. According to the American Heart Association, ICAD is responsible for 10-15% of all ischemic strokes in the United States. The disease is more common in certain populations such as Asians, Hispanics, and Africans, making it a significant public health concern in these populations. The increasing prevalence of ICAD is expected to drive the demand for effective diagnostic and treatment options.

The introduction of advanced imaging technologies is another factor driving the ICAD pathology market. Advanced imaging technologies such as magnetic resonance imaging (MRI) and computed tomography (CT) scans have significantly improved the accuracy of ICAD diagnosis. This has led to an increase in the number of patients being diagnosed with ICAD, driving the demand for treatment options. The development of innovative treatment options is also driving the ICAD pathology market. Several companies are developing new drugs and therapies for ICAD, including antiplatelet agents, anticoagulants, and angioplasty. These treatments have the potential to improve patient outcomes and reduce the risk of stroke.

However, there are also some restraints to the ICAD pathology market. The high cost of treatment and the lack of awareness of the disease in certain populations may limit the market growth. Additionally, the COVID-19 pandemic has had a significant impact on the healthcare industry, leading to disruptions in the supply chain and delaying clinical trials for new treatments.

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1118

Key Players Influencing the Intracranial Atherosclerotic Disease (ICAD) Pathology Market:

Acandis GmbH, BALT group., Boston Scientific Corporation, CERENOVUS, Medtronic, MicroPort Scientific Corporation, Stryker, Terumo Corporation, Other Market Participants

Ask for discount on this report: https://www.absolutemarketsinsights.com/ask_for_discount.php?id=1118

Study Objectives of this Report:
Detailed overview of market.
Changing market dynamics of the industry.
In-depth market segmentation by Type, Application etc.
Historical, current and projected market size in terms of volume and value.
Recent industry trends and developments.
Competitive landscape of market.
Strategies of key players and product offerings.
Potential and niche segments/regions exhibiting promising growth.
A neutral perspective towards market performance.
Market players' information to sustain and enhance their footprint.

Purchase the latest in-depth Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1118

Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market:

By Product Type
Stent
PTA Balloon Catheter

By Diagnosis/imaging techniques
High-definition MRI
Balloon test occlusion
Computed tomographic angiogram (CTA)
Transcranial Doppler ultrasound (TCD)
Digital subtraction angiography (DSA)
Others

By End Users
Hospitals
Clinics
Diagnostic centers
Others

By Region
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1118

We appreciate your reading the article in its entirety. If you would like to know more about the Intracranial Atherosclerotic Disease (ICAD) Pathology market, looking for customization, contact us. To achieve a full market reach of Intracranial Atherosclerotic Disease (ICAD) Pathology, or explore more about opportunities reach our research analyst. Our team is available 24/7 to assist and support our customers through reliable research.

View our exclusive press releases on Industry Global News24 - https://industryglobalnews24.com

Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com

About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

This release was published on openPR.